UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Accumulated Deficit	Total
Balances, beginning of period at Dec. 31, 2023	$ 476,354	$ (471,403)	$ 4,951
Balances, beginning of period (in shares) at Dec. 31, 2023	121,088,494
Shares issued, net of offering costs	$ 53		53
Shares issued, net of offering costs (in shares)	100,000
Shares issued (RSUs vested, net of shares withheld)	$ (85)		(85)
Shares issued (RSUs vested, net of shares withheld) (in shares)	445,551
Stock-based compensation	$ 291		291
Net loss		(1,073)	(1,073)
Balances, end of period at Mar. 31, 2024	$ 476,613	(472,476)	4,137
Balances, end of period (in shares) at Mar. 31, 2024	121,634,045
Balances, beginning of period at Dec. 31, 2024	$ 478,061	(460,154)	17,907
Balances, beginning of period (in shares) at Dec. 31, 2024	123,552,011
Shares issued, net of offering costs	$ 269		269
Shares issued, net of offering costs (in shares)	400,000
Shares issued (RSUs vested, net of shares withheld)	$ (245)		(245)
Shares issued (RSUs vested, net of shares withheld) (in shares)	603,491
Stock-based compensation	$ 359		359
Net loss		(2,708)	(2,708)
Balances, end of period at Mar. 31, 2025	$ 478,444	$ (462,862)	$ 15,582
Balances, end of period (in shares) at Mar. 31, 2025	124,555,502